nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—ALB—melanoma	0.244	1	CbGaD
Isoflurane—ALB—Vemurafenib—melanoma	0.0439	0.558	CbGbCtD
Isoflurane—CYP2E1—Dacarbazine—melanoma	0.0348	0.442	CbGbCtD
Isoflurane—Halothane—GRIN2A—melanoma	0.00846	0.671	CrCbGaD
Isoflurane—ATP2C1—skin epidermis—melanoma	0.00755	0.0462	CbGeAlD
Isoflurane—CALM2—ear—melanoma	0.00591	0.0362	CbGeAlD
Isoflurane—CALM1—ear—melanoma	0.00589	0.036	CbGeAlD
Isoflurane—ATP2C1—hair follicle—melanoma	0.00539	0.033	CbGeAlD
Isoflurane—ND1—neck—melanoma	0.00455	0.0278	CbGeAlD
Isoflurane—GABRE—hair follicle—melanoma	0.00403	0.0247	CbGeAlD
Isoflurane—GRIA1—eye—melanoma	0.00393	0.024	CbGeAlD
Isoflurane—GRIA1—retina—melanoma	0.0039	0.0238	CbGeAlD
Isoflurane—KCNA1—retina—melanoma	0.0038	0.0233	CbGeAlD
Isoflurane—GABRA3—neck—melanoma	0.00366	0.0224	CbGeAlD
Isoflurane—Traumatic liver injury—Temozolomide—melanoma	0.00364	0.0778	CcSEcCtD
Isoflurane—CALM2—endothelium—melanoma	0.00317	0.0194	CbGeAlD
Isoflurane—CALM1—endothelium—melanoma	0.00316	0.0193	CbGeAlD
Isoflurane—CALM2—hair follicle—melanoma	0.00312	0.0191	CbGeAlD
Isoflurane—KCNK10—head—melanoma	0.00307	0.0188	CbGeAlD
Isoflurane—KCNK9—head—melanoma	0.00305	0.0187	CbGeAlD
Isoflurane—ND1—skin of body—melanoma	0.00294	0.018	CbGeAlD
Isoflurane—CALM2—blood vessel—melanoma	0.00292	0.0179	CbGeAlD
Isoflurane—CALM1—blood vessel—melanoma	0.00291	0.0178	CbGeAlD
Isoflurane—KCNK3—head—melanoma	0.00277	0.0169	CbGeAlD
Isoflurane—ATP2C1—retina—melanoma	0.00267	0.0163	CbGeAlD
Isoflurane—GABRQ—head—melanoma	0.00247	0.0151	CbGeAlD
Isoflurane—GLRB—head—melanoma	0.0024	0.0147	CbGeAlD
Isoflurane—ATP2C1—skin of body—melanoma	0.00234	0.0143	CbGeAlD
Isoflurane—GRIA1—head—melanoma	0.00223	0.0137	CbGeAlD
Isoflurane—KCNA1—head—melanoma	0.00218	0.0133	CbGeAlD
Isoflurane—ATP5D—mammalian vulva—melanoma	0.00216	0.0132	CbGeAlD
Isoflurane—GABRG3—head—melanoma	0.00216	0.0132	CbGeAlD
Isoflurane—ATP2C1—mammalian vulva—melanoma	0.00213	0.0131	CbGeAlD
Isoflurane—GABRA4—mammalian vulva—melanoma	0.00211	0.0129	CbGeAlD
Isoflurane—CALM2—neck—melanoma	0.00209	0.0128	CbGeAlD
Isoflurane—CALM1—neck—melanoma	0.00208	0.0127	CbGeAlD
Isoflurane—KCNK2—lymph node—melanoma	0.00201	0.0123	CbGeAlD
Isoflurane—CALM3—eye—melanoma	0.00198	0.0121	CbGeAlD
Isoflurane—CALM3—retina—melanoma	0.00196	0.012	CbGeAlD
Isoflurane—ND1—head—melanoma	0.00192	0.0117	CbGeAlD
Isoflurane—Necrosis—Dactinomycin—melanoma	0.00191	0.0408	CcSEcCtD
Isoflurane—GABRD—head—melanoma	0.00179	0.0109	CbGeAlD
Isoflurane—Necrosis—Carmustine—melanoma	0.00179	0.0382	CcSEcCtD
Isoflurane—GABRG1—head—melanoma	0.00172	0.0105	CbGeAlD
Isoflurane—GABRA6—head—melanoma	0.00171	0.0105	CbGeAlD
Isoflurane—GABRB3—eye—melanoma	0.00171	0.0104	CbGeAlD
Isoflurane—GLRB—lymph node—melanoma	0.00168	0.0103	CbGeAlD
Isoflurane—GABRB1—head—melanoma	0.00167	0.0102	CbGeAlD
Isoflurane—GABRA5—head—melanoma	0.00166	0.0102	CbGeAlD
Isoflurane—Enflurane—ALB—melanoma	0.00163	0.13	CrCbGaD
Isoflurane—Liver injury—Temozolomide—melanoma	0.00161	0.0344	CcSEcCtD
Isoflurane—GABRE—mammalian vulva—melanoma	0.0016	0.00977	CbGeAlD
Isoflurane—CALM3—mammalian vulva—melanoma	0.00157	0.00961	CbGeAlD
Isoflurane—CALM2—eye—melanoma	0.00156	0.00952	CbGeAlD
Isoflurane—CALM1—eye—melanoma	0.00155	0.00947	CbGeAlD
Isoflurane—GABRA3—head—melanoma	0.00155	0.00946	CbGeAlD
Isoflurane—ATP5D—head—melanoma	0.00155	0.00946	CbGeAlD
Isoflurane—CALM2—retina—melanoma	0.00154	0.00943	CbGeAlD
Isoflurane—CALM1—retina—melanoma	0.00153	0.00939	CbGeAlD
Isoflurane—ATP2C1—head—melanoma	0.00153	0.00934	CbGeAlD
Isoflurane—GABRA4—head—melanoma	0.00151	0.00922	CbGeAlD
Isoflurane—GABRP—head—melanoma	0.0015	0.00915	CbGeAlD
Isoflurane—CALM2—skin of body—melanoma	0.00135	0.00828	CbGeAlD
Isoflurane—CALM1—skin of body—melanoma	0.00135	0.00824	CbGeAlD
Isoflurane—ND1—lymph node—melanoma	0.00134	0.00822	CbGeAlD
Isoflurane—Halothane—ALB—melanoma	0.00134	0.106	CrCbGaD
Isoflurane—Ileus—Docetaxel—melanoma	0.00127	0.0272	CcSEcCtD
Isoflurane—GABRG2—head—melanoma	0.00126	0.00771	CbGeAlD
Isoflurane—GABRB2—head—melanoma	0.00126	0.00771	CbGeAlD
Isoflurane—Cardiac disorder—Vemurafenib—melanoma	0.00124	0.0264	CcSEcCtD
Isoflurane—CALM2—mammalian vulva—melanoma	0.00123	0.00755	CbGeAlD
Isoflurane—CALM1—mammalian vulva—melanoma	0.00123	0.00752	CbGeAlD
Isoflurane—Hepatic failure—Dactinomycin—melanoma	0.00121	0.0259	CcSEcCtD
Isoflurane—Chills—Vemurafenib—melanoma	0.00119	0.0256	CcSEcCtD
Isoflurane—Desflurane—ALB—melanoma	0.00119	0.094	CrCbGaD
Isoflurane—GABRA2—head—melanoma	0.00115	0.00705	CbGeAlD
Isoflurane—Necrosis—Docetaxel—melanoma	0.00115	0.0246	CcSEcCtD
Isoflurane—GABRE—head—melanoma	0.00114	0.00699	CbGeAlD
Isoflurane—GABRA1—head—melanoma	0.00111	0.00681	CbGeAlD
Isoflurane—Hepatic failure—Temozolomide—melanoma	0.00109	0.0234	CcSEcCtD
Isoflurane—ATP5D—lymph node—melanoma	0.00108	0.00663	CbGeAlD
Isoflurane—ATP2C1—lymph node—melanoma	0.00107	0.00654	CbGeAlD
Isoflurane—Cough—Vemurafenib—melanoma	0.00101	0.0216	CcSEcCtD
Isoflurane—CYP2B6—skin of body—melanoma	0.00101	0.00615	CbGeAlD
Isoflurane—Bronchospasm—Bleomycin—melanoma	0.000991	0.0212	CcSEcCtD
Isoflurane—GABRB3—head—melanoma	0.000969	0.00592	CbGeAlD
Isoflurane—Hepatocellular injury—Docetaxel—melanoma	0.000901	0.0193	CcSEcCtD
Isoflurane—Hypotension—Vemurafenib—melanoma	0.000884	0.0189	CcSEcCtD
Isoflurane—CALM2—head—melanoma	0.000883	0.0054	CbGeAlD
Isoflurane—CALM1—head—melanoma	0.000879	0.00538	CbGeAlD
Isoflurane—GABRA2—lymph node—melanoma	0.000807	0.00493	CbGeAlD
Isoflurane—GABRE—lymph node—melanoma	0.0008	0.00489	CbGeAlD
Isoflurane—Hyperglycaemia—Carmustine—melanoma	0.000793	0.017	CcSEcCtD
Isoflurane—CALM3—lymph node—melanoma	0.000788	0.00482	CbGeAlD
Isoflurane—Hyperglycaemia—Temozolomide—melanoma	0.000767	0.0164	CcSEcCtD
Isoflurane—Hepatitis—Dactinomycin—melanoma	0.000752	0.0161	CcSEcCtD
Isoflurane—Body temperature increased—Vemurafenib—melanoma	0.000748	0.016	CcSEcCtD
Isoflurane—ALB—lymph node—melanoma	0.000729	0.00446	CbGeAlD
Isoflurane—Hepatic failure—Docetaxel—melanoma	0.000728	0.0156	CcSEcCtD
Isoflurane—Chills—Bleomycin—melanoma	0.000724	0.0155	CcSEcCtD
Isoflurane—Hepatobiliary disease—Temozolomide—melanoma	0.000717	0.0153	CcSEcCtD
Isoflurane—Hallucination—Carmustine—melanoma	0.000701	0.015	CcSEcCtD
Isoflurane—Hepatitis—Temozolomide—melanoma	0.00068	0.0146	CcSEcCtD
Isoflurane—Hallucination—Temozolomide—melanoma	0.000677	0.0145	CcSEcCtD
Isoflurane—Chills—Dactinomycin—melanoma	0.000675	0.0144	CcSEcCtD
Isoflurane—CYP2B6—head—melanoma	0.000657	0.00402	CbGeAlD
Isoflurane—Cardiac disorder—Temozolomide—melanoma	0.000631	0.0135	CcSEcCtD
Isoflurane—Arrhythmia—Carmustine—melanoma	0.000629	0.0135	CcSEcCtD
Isoflurane—CALM2—lymph node—melanoma	0.000619	0.00378	CbGeAlD
Isoflurane—CYP2E1—head—melanoma	0.000616	0.00377	CbGeAlD
Isoflurane—CALM1—lymph node—melanoma	0.000616	0.00376	CbGeAlD
Isoflurane—Cough—Bleomycin—melanoma	0.000613	0.0131	CcSEcCtD
Isoflurane—Chills—Temozolomide—melanoma	0.000611	0.0131	CcSEcCtD
Isoflurane—Vomiting—Vemurafenib—melanoma	0.000601	0.0129	CcSEcCtD
Isoflurane—Rash—Vemurafenib—melanoma	0.000596	0.0128	CcSEcCtD
Isoflurane—Dermatitis—Vemurafenib—melanoma	0.000596	0.0127	CcSEcCtD
Isoflurane—Agitation—Carmustine—melanoma	0.000563	0.012	CcSEcCtD
Isoflurane—Nausea—Vemurafenib—melanoma	0.000562	0.012	CcSEcCtD
Isoflurane—Bronchospasm—Docetaxel—melanoma	0.000556	0.0119	CcSEcCtD
Isoflurane—Agitation—Temozolomide—melanoma	0.000544	0.0116	CcSEcCtD
Isoflurane—Hypotension—Bleomycin—melanoma	0.000535	0.0115	CcSEcCtD
Isoflurane—Cough—Temozolomide—melanoma	0.000517	0.0111	CcSEcCtD
Isoflurane—Jaundice—Docetaxel—melanoma	0.000491	0.0105	CcSEcCtD
Isoflurane—Hepatobiliary disease—Docetaxel—melanoma	0.000477	0.0102	CcSEcCtD
Isoflurane—Hypotension—Carmustine—melanoma	0.000467	0.01	CcSEcCtD
Isoflurane—Body temperature increased—Bleomycin—melanoma	0.000453	0.00969	CcSEcCtD
Isoflurane—Hepatitis—Docetaxel—melanoma	0.000452	0.00968	CcSEcCtD
Isoflurane—Body temperature increased—Dactinomycin—melanoma	0.000422	0.00904	CcSEcCtD
Isoflurane—Cardiac disorder—Docetaxel—melanoma	0.00042	0.00898	CcSEcCtD
Isoflurane—Chills—Docetaxel—melanoma	0.000406	0.00868	CcSEcCtD
Isoflurane—Arrhythmia—Docetaxel—melanoma	0.000404	0.00865	CcSEcCtD
Isoflurane—Body temperature increased—Carmustine—melanoma	0.000395	0.00846	CcSEcCtD
Isoflurane—Body temperature increased—Temozolomide—melanoma	0.000382	0.00817	CcSEcCtD
Isoflurane—Vomiting—Bleomycin—melanoma	0.000364	0.00779	CcSEcCtD
Isoflurane—Rash—Bleomycin—melanoma	0.000361	0.00773	CcSEcCtD
Isoflurane—Dermatitis—Bleomycin—melanoma	0.000361	0.00772	CcSEcCtD
Isoflurane—Cough—Docetaxel—melanoma	0.000344	0.00735	CcSEcCtD
Isoflurane—Nausea—Bleomycin—melanoma	0.00034	0.00728	CcSEcCtD
Isoflurane—Vomiting—Dactinomycin—melanoma	0.00034	0.00727	CcSEcCtD
Isoflurane—Rash—Dactinomycin—melanoma	0.000337	0.00721	CcSEcCtD
Isoflurane—Vomiting—Carmustine—melanoma	0.000318	0.0068	CcSEcCtD
Isoflurane—Nausea—Dactinomycin—melanoma	0.000317	0.00679	CcSEcCtD
Isoflurane—Rash—Carmustine—melanoma	0.000315	0.00675	CcSEcCtD
Isoflurane—Dermatitis—Carmustine—melanoma	0.000315	0.00674	CcSEcCtD
Isoflurane—Vomiting—Temozolomide—melanoma	0.000307	0.00657	CcSEcCtD
Isoflurane—Rash—Temozolomide—melanoma	0.000305	0.00652	CcSEcCtD
Isoflurane—Dermatitis—Temozolomide—melanoma	0.000305	0.00651	CcSEcCtD
Isoflurane—Hypotension—Docetaxel—melanoma	0.0003	0.00643	CcSEcCtD
Isoflurane—Nausea—Carmustine—melanoma	0.000297	0.00636	CcSEcCtD
Isoflurane—Nausea—Temozolomide—melanoma	0.000287	0.00614	CcSEcCtD
Isoflurane—Body temperature increased—Docetaxel—melanoma	0.000254	0.00544	CcSEcCtD
Isoflurane—Vomiting—Docetaxel—melanoma	0.000204	0.00437	CcSEcCtD
Isoflurane—Rash—Docetaxel—melanoma	0.000203	0.00434	CcSEcCtD
Isoflurane—Dermatitis—Docetaxel—melanoma	0.000203	0.00433	CcSEcCtD
Isoflurane—Nausea—Docetaxel—melanoma	0.000191	0.00408	CcSEcCtD
Isoflurane—ALB—Metabolism—PPARG—melanoma	7.56e-06	1.67e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CDKN1B—melanoma	7.52e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CDKN1B—melanoma	7.52e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CDKN1A—melanoma	7.52e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CDKN1A—melanoma	7.52e-06	1.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PTEN—melanoma	7.5e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PTEN—melanoma	7.5e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NOTCH1—melanoma	7.49e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NOTCH1—melanoma	7.49e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EGF—melanoma	7.49e-06	1.65e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NFKB1—melanoma	7.47e-06	1.64e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NFKB1—melanoma	7.47e-06	1.64e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—AKT1—melanoma	7.42e-06	1.63e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—AKT1—melanoma	7.42e-06	1.63e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—AKT1—melanoma	7.37e-06	1.62e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—AKT1—melanoma	7.37e-06	1.62e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CTNNB1—melanoma	7.35e-06	1.62e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CD80—melanoma	7.34e-06	1.62e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CD80—melanoma	7.34e-06	1.62e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—APC—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—APC—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CG—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CG—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KIT—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KIT—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—NRAS—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—NRAS—melanoma	7.33e-06	1.61e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—MAPK3—melanoma	7.25e-06	1.6e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EGF—melanoma	7.24e-06	1.59e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EGF—melanoma	7.24e-06	1.59e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CDKN1A—melanoma	7.18e-06	1.58e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PTEN—melanoma	7.16e-06	1.58e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PIK3CB—melanoma	7.13e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—AKT1—melanoma	7.13e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—AKT1—melanoma	7.13e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—BRAF—melanoma	7.12e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CTNNB1—melanoma	7.11e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CTNNB1—melanoma	7.11e-06	1.57e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTGS2—melanoma	7.07e-06	1.56e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—MAPK3—melanoma	7.02e-06	1.55e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—MAPK3—melanoma	7.02e-06	1.55e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PIK3CB—melanoma	6.98e-06	1.54e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CDKN1A—melanoma	6.94e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CDKN1A—melanoma	6.94e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PIK3CB—melanoma	6.94e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—STAT3—melanoma	6.94e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IGF1—melanoma	6.93e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PTEN—melanoma	6.93e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PTEN—melanoma	6.93e-06	1.53e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTGS2—melanoma	6.92e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—NRAS—melanoma	6.92e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—MAPK1—melanoma	6.9e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—EGFR—melanoma	6.9e-06	1.52e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PIK3CD—melanoma	6.89e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—BRAF—melanoma	6.89e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—BRAF—melanoma	6.89e-06	1.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTGS2—melanoma	6.88e-06	1.51e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PIK3CB—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PIK3CB—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—STAT3—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—STAT3—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF1—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF1—melanoma	6.71e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MAP2K1—melanoma	6.7e-06	1.48e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NRAS—melanoma	6.69e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NRAS—melanoma	6.69e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—MAPK1—melanoma	6.68e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—MAPK1—melanoma	6.68e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—EGFR—melanoma	6.67e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—EGFR—melanoma	6.67e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PIK3CD—melanoma	6.66e-06	1.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTGS2—melanoma	6.65e-06	1.46e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTGS2—melanoma	6.65e-06	1.46e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—MAPK3—melanoma	6.63e-06	1.46e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—KRAS—melanoma	6.52e-06	1.44e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MAP2K1—melanoma	6.48e-06	1.43e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MAP2K1—melanoma	6.48e-06	1.43e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CD—melanoma	6.44e-06	1.42e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CD—melanoma	6.44e-06	1.42e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—MAPK3—melanoma	6.41e-06	1.41e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—MAPK3—melanoma	6.41e-06	1.41e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—STAT3—melanoma	6.4e-06	1.41e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—NRAS—melanoma	6.39e-06	1.41e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FGF2—melanoma	6.37e-06	1.4e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—MAPK1—melanoma	6.31e-06	1.39e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—KRAS—melanoma	6.31e-06	1.39e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—KRAS—melanoma	6.31e-06	1.39e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—EGFR—melanoma	6.3e-06	1.39e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—STAT3—melanoma	6.2e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—STAT3—melanoma	6.2e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—NRAS—melanoma	6.18e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—NRAS—melanoma	6.18e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FGF2—melanoma	6.17e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FGF2—melanoma	6.17e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PTEN—melanoma	6.16e-06	1.36e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MAPK3—melanoma	6.12e-06	1.35e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—MAPK1—melanoma	6.1e-06	1.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—MAPK1—melanoma	6.1e-06	1.34e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—EGFR—melanoma	6.1e-06	1.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—EGFR—melanoma	6.1e-06	1.34e-05	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PTEN—melanoma	6.04e-06	1.33e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PIK3CB—melanoma	6e-06	1.32e-05	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PTEN—melanoma	6e-06	1.32e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—PIK3CA—melanoma	5.99e-06	1.32e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MDM2—melanoma	5.96e-06	1.31e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KRAS—melanoma	5.96e-06	1.31e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MYC—melanoma	5.95e-06	1.31e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTGS2—melanoma	5.95e-06	1.31e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MAPK3—melanoma	5.92e-06	1.3e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MAPK3—melanoma	5.92e-06	1.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ERBB2—melanoma	5.88e-06	1.3e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MAPK1—melanoma	5.82e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—EGFR—melanoma	5.82e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PIK3CB—melanoma	5.8e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PTEN—melanoma	5.8e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PTEN—melanoma	5.8e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—PIK3CA—melanoma	5.79e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—PIK3CA—melanoma	5.79e-06	1.28e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MDM2—melanoma	5.77e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MDM2—melanoma	5.77e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KRAS—melanoma	5.76e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KRAS—melanoma	5.76e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MYC—melanoma	5.76e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MYC—melanoma	5.76e-06	1.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ERBB2—melanoma	5.69e-06	1.25e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ERBB2—melanoma	5.69e-06	1.25e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MAPK1—melanoma	5.63e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MAPK1—melanoma	5.63e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—EGFR—melanoma	5.63e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—EGFR—melanoma	5.63e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CB—melanoma	5.61e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CB—melanoma	5.61e-06	1.24e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CXCL8—melanoma	5.58e-06	1.23e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—HRAS—melanoma	5.54e-06	1.22e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—KRAS—melanoma	5.5e-06	1.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PIK3CA—melanoma	5.47e-06	1.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CDKN1B—melanoma	5.45e-06	1.2e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CXCL8—melanoma	5.39e-06	1.19e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CXCL8—melanoma	5.39e-06	1.19e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—HRAS—melanoma	5.36e-06	1.18e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—HRAS—melanoma	5.36e-06	1.18e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CASP3—melanoma	5.34e-06	1.18e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL2—melanoma	5.33e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—KRAS—melanoma	5.32e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—KRAS—melanoma	5.32e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—IL6—melanoma	5.3e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PIK3CA—melanoma	5.29e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PIK3CA—melanoma	5.29e-06	1.17e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CDKN1B—melanoma	5.27e-06	1.16e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CDKN1B—melanoma	5.27e-06	1.16e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCND1—melanoma	5.2e-06	1.14e-05	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PTEN—melanoma	5.19e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CASP3—melanoma	5.16e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CASP3—melanoma	5.16e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL2—melanoma	5.16e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL2—melanoma	5.16e-06	1.14e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CTNNB1—melanoma	5.14e-06	1.13e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—IL6—melanoma	5.13e-06	1.13e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—IL6—melanoma	5.13e-06	1.13e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—HRAS—melanoma	5.06e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—PIK3CA—melanoma	5.05e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MMP9—melanoma	5.04e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CDKN1A—melanoma	5.03e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCND1—melanoma	5.03e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCND1—melanoma	5.03e-06	1.11e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PTEN—melanoma	5.01e-06	1.1e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NFKB1—melanoma	4.99e-06	1.1e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CTNNB1—melanoma	4.98e-06	1.1e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CTNNB1—melanoma	4.98e-06	1.1e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—HRAS—melanoma	4.9e-06	1.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—HRAS—melanoma	4.9e-06	1.08e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—AKT1—melanoma	4.89e-06	1.08e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—PIK3CA—melanoma	4.89e-06	1.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—PIK3CA—melanoma	4.89e-06	1.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MMP9—melanoma	4.88e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MMP9—melanoma	4.88e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CDKN1A—melanoma	4.86e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CDKN1A—melanoma	4.86e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PTEN—melanoma	4.85e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PTEN—melanoma	4.85e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL6—melanoma	4.85e-06	1.07e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NFKB1—melanoma	4.83e-06	1.06e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NFKB1—melanoma	4.83e-06	1.06e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—AKT1—melanoma	4.73e-06	1.04e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—AKT1—melanoma	4.73e-06	1.04e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL6—melanoma	4.69e-06	1.03e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL6—melanoma	4.69e-06	1.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—HRAS—melanoma	4.67e-06	1.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—VEGFA—melanoma	4.53e-06	9.97e-06	CbGpPWpGaD
Isoflurane—CALM1—Disease—HRAS—melanoma	4.52e-06	9.96e-06	CbGpPWpGaD
Isoflurane—CALM2—Disease—HRAS—melanoma	4.52e-06	9.96e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—STAT3—melanoma	4.48e-06	9.88e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NRAS—melanoma	4.47e-06	9.85e-06	CbGpPWpGaD
Isoflurane—CALM3—Disease—IL6—melanoma	4.47e-06	9.85e-06	CbGpPWpGaD
Isoflurane—CALM3—Immune System—AKT1—melanoma	4.47e-06	9.84e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—VEGFA—melanoma	4.38e-06	9.65e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—VEGFA—melanoma	4.38e-06	9.65e-06	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—PIK3CA—melanoma	4.35e-06	9.57e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—STAT3—melanoma	4.34e-06	9.55e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—STAT3—melanoma	4.34e-06	9.55e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NRAS—melanoma	4.33e-06	9.53e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NRAS—melanoma	4.33e-06	9.53e-06	CbGpPWpGaD
Isoflurane—CALM1—Disease—IL6—melanoma	4.33e-06	9.53e-06	CbGpPWpGaD
Isoflurane—CALM2—Disease—IL6—melanoma	4.33e-06	9.53e-06	CbGpPWpGaD
Isoflurane—CALM2—Immune System—AKT1—melanoma	4.32e-06	9.52e-06	CbGpPWpGaD
Isoflurane—CALM1—Immune System—AKT1—melanoma	4.32e-06	9.52e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MAPK3—melanoma	4.28e-06	9.44e-06	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—PIK3CA—melanoma	4.26e-06	9.38e-06	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—PIK3CA—melanoma	4.23e-06	9.32e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MYC—melanoma	4.17e-06	9.18e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MAPK3—melanoma	4.14e-06	9.13e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MAPK3—melanoma	4.14e-06	9.13e-06	CbGpPWpGaD
Isoflurane—CALM3—Disease—AKT1—melanoma	4.13e-06	9.09e-06	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—PIK3CA—melanoma	4.09e-06	9.01e-06	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PIK3CA—melanoma	4.09e-06	9.01e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MAPK1—melanoma	4.08e-06	8.98e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EGFR—melanoma	4.08e-06	8.98e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MYC—melanoma	4.03e-06	8.88e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MYC—melanoma	4.03e-06	8.88e-06	CbGpPWpGaD
Isoflurane—CALM2—Disease—AKT1—melanoma	3.99e-06	8.79e-06	CbGpPWpGaD
Isoflurane—CALM1—Disease—AKT1—melanoma	3.99e-06	8.79e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MAPK1—melanoma	3.94e-06	8.69e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MAPK1—melanoma	3.94e-06	8.69e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EGFR—melanoma	3.94e-06	8.68e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EGFR—melanoma	3.94e-06	8.68e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KRAS—melanoma	3.85e-06	8.48e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KRAS—melanoma	3.72e-06	8.2e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KRAS—melanoma	3.72e-06	8.2e-06	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PIK3CA—melanoma	3.66e-06	8.06e-06	CbGpPWpGaD
Isoflurane—CYP2B6—Metabolism—AKT1—melanoma	3.55e-06	7.82e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PIK3CA—melanoma	3.54e-06	7.79e-06	CbGpPWpGaD
Isoflurane—CYP2E1—Metabolism—AKT1—melanoma	3.48e-06	7.66e-06	CbGpPWpGaD
Isoflurane—CALM3—Metabolism—AKT1—melanoma	3.46e-06	7.61e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TP53—melanoma	3.42e-06	7.54e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PIK3CA—melanoma	3.42e-06	7.54e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PIK3CA—melanoma	3.42e-06	7.54e-06	CbGpPWpGaD
Isoflurane—CALM1—Metabolism—AKT1—melanoma	3.34e-06	7.36e-06	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—AKT1—melanoma	3.34e-06	7.36e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TP53—melanoma	3.31e-06	7.29e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TP53—melanoma	3.31e-06	7.29e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—HRAS—melanoma	3.27e-06	7.21e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—HRAS—melanoma	3.17e-06	6.97e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—HRAS—melanoma	3.17e-06	6.97e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL6—melanoma	3.13e-06	6.9e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL6—melanoma	3.03e-06	6.67e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL6—melanoma	3.03e-06	6.67e-06	CbGpPWpGaD
Isoflurane—ALB—Metabolism—AKT1—melanoma	2.99e-06	6.58e-06	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—AKT1—melanoma	2.89e-06	6.36e-06	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—AKT1—melanoma	2.8e-06	6.16e-06	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—AKT1—melanoma	2.8e-06	6.16e-06	CbGpPWpGaD
